Barrett, B, Waheed, W, Farrelly, S et al (2013) Randomised controlled trial
of joint crisis plans to reduce compulsory treatment for people with
psychosis: economic outcomes. PLoS ONE,
Brazier, J, Ratcliffe, J, Salomon, J et al (2007) Measuring and Valuing Health
Benefits for Economic Evaluation. Oxford
Briggs, A, Claxton, K, Sculpher, M (2006) Decision Modelling for Health Economic
Evaluation. Oxford University
Brooks, R (1996) EuroQol: the current state of
play. Health Policy,
Byford, S, Palmer, S (1998) Common errors and controversies
in pharmacoeconomic analyses.
Byford, S, McDaid, D, Sefton, T (2003) Because It's Worth It: A Practical Guide
to Conducting Economic Evaluations in the Social Welfare Field.
Byford, S, Barrett, B (2010) Ethics and economics: the case
for mental heathcare. Advances in Psychiatric
Treatment, 16: 468–73.
Byford, S, Barrett, B, Metrebian, N et al (2013) Cost-effectiveness of
injectable opioid treatment v. oral methadone for
chronic heroin addiction. British Journal of
Psychiatry, 203: 341–9.
Claxton, K, Sculpher, M, Palmer, S et al (2015) Causes for concern: is NICE
failing to uphold its responsibilities to all NHS
Health Economics, 24:
Curtis, L (ed) (2014) PSSRU Unit Costs of Health and
Social Care 2014. Personal Social Services
Drummond, M, Jefferson, T (1996) Guidelines for authors and peer
reviewers of economic submissions to the BMJ.
BMJ, 313: 275–83.
Drummond, M, Sculpher, M, Torrance, G et al (2005) Methods for the Economic
Evaluation of Health Care Programmes. Oxford
Fenwick, E, Byford, S (2005) A guide to cost-effectiveness
acceptability curves. British Journal of
Psychiatry, 187: 106–8.
Fineberg, NA, Haddad, PM, Carpenter, L et al (2013) The size, burden and cost
of disorders of the brain in the UK. Journal of
Gold, M, Siegel, J, Russell, L et al (1996) Cost-Effectiveness in Health and
Medicine. Oxford University
Guiness, L, Wiseman, V (2011) Introduction to Health
Economics (2nd edn). Open
Jacobs, R (2014) Payment by results for mental
health services: economic considerations of case-mix
funding. Advances in Psychiatric
Treatment, 20: 155–64.
Mauskopf, J, Paul, J, Grant, D et al (1998) The role of
cost-consequences analysis in healthcare decision-making.
McCrone, PR, Dhanasiri, S, Patel, A et al (2008) Paying the Price: The Cost of
Mental Health Care in England to 2026. King's
McIntosh, E, Clarke, P, Frew, E et al (2010) Applied Methods of Cost-Benefit
Analysis in Health Care. Oxford University
Mulhern, B, Mukuria, C, Barkham, M et al (2014) Using generic
preference-based measures in mental health: psychometric validity of the
EQ-5D and SF-6D. British Journal of
Psychiatry, 205: 236–43.
National Institute for Health and Care Excellence
(2013) Guide to the Methods of Technology Appraisal
2013 (Process and Methods Guides PMG9).
Norman, I, Coster, S, McCrone, P et al (2010) A comparison of the
clinical effectiveness and costs of mental health nurse supplementary
prescribing and independent medical prescribing: a post-test control
group study. BMC Health Services
Petrou, S, Gray, A (2011a) Economic evaluation alongside
randomised controlled trials: design, conduct, analysis, and
reporting. BMJ, 342:
Petrou, S, Gray, A (2011b) Economic evaluation using
decision analytical modelling: design, conduct, analysis, and
reporting. BMJ, 342:
Ridyard, CH, Hughes, DA (2012) Development of a database of
instruments for resource-use measurement: purpose, feasibility, and
design. Value in Health,
Robinson, R (1993) Economic evaluation and health
care: what does it mean?
BMJ, 307: 670–3.
Shanahan, M, Ritter, A (2014) Cost-benefit analysis of two
policy options for cannabis: status quo and legalisation.
PLoS ONE, 9(4):
Van Hout, BA, Al, MJ, Gordon, GS et al (1994) Costs, effects and
C/E-ratios alongside a clinical trial. Health
Economics, 3: 309–19.